Two cases of valproic acid poisoning treated with l-carnitine

Abstract

Two cases of acute valproic acid poisoning with central nervous system depression and raised ammonia level without hepatotoxicity were reported. They were treated successfully with the use of the antidotes: l-carnitine and other supportive measures. Clinical manifestation and progress was described, and discussion is focused on the use of l-carnitine in valproic acid–induced hyperammonemia, from its mechanism to the clinical experiences in the literature. Based on the favorable response of our two cases and the literature review, we recommend the administration of intravenous l-carnitine in patients of valproic acid overdose with hyperammonemia or valproic acid–induced hyperammonemic encephalopathy and hepatotoxicity at a dose of 50 mg/kg every 8 h for the first initial 24 h with further individual assessment.

Keywords

antidotes l-carnitine poisoning valproic acid

References

1 Watson WA Litovitz TL Rodgers QC Klein-Schwartz V Reid N Youniss J . 2004 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005; 23: 589 – 666 .

2 Sztajnkrycer MD . Valproic acid toxicity: overview and management. J Toxicol Clin Toxicol 2002; 40: 789 – 801 .

3 Raskind JY El-Chaar GM . The role of carnitine supplementation during valproic acid therapy. Ann Pharmacother 2000; 34: 630 – 638 .

4 Verrotti A Trotta D Morgese G Chiarelli F . Valproate-induced hyperammonemic encephalopathy. Metab Brain Dis 2002; 17: 367 – 373 .

5 Barrueto F Hack JB . Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy. Acad Emerg Med 2001; 8: 999 – 1001 .

6 Bohnan TP Helton E McDonald I König S Gazitt S Sugimoto T . Effect of l-carnitine treatment for valproate-induced hepatotoxicity. Neurology 2001; 56: 1405 – 1409 .

8 LoVecchio F Shriki J Samaddar R . l-Carnitine was safely administered in the setting of valproate toxicity. Am J Emerg Med 2005; 23: 321 – 322 .